- Clorox press release ( NYSE: CLX ): Q1 Non-GAAP EPS of $0.93 beats by $0.15 .
- Revenue of $1.74B (-3.9% Y/Y) beats by $40M .
- Gross margin decreased 110 basis points to 36% from 37.1% in the year-ago quarter.
- FY 2023 Guidance: Net sales from a 4% decrease to a 2% increase compared to the prior year (organic sales from a 3% decrease to a 3% increase).
- Foreign exchange headwinds now represent about a 2-point reduction in sales from 1.5 points assumed in the prior outlook.
- Gross margin increase of about 200 basis points
- Advertising and sales promotion spending of about 10% of net sales
- Diluted EPS between $3.10 and $3.47, or a 17% to 7% decrease, respectively.
- Adjusted EPS between $3.85 and $4.22, or a 6% decrease to a 3% increase, respectively, vs. consensus of $4.06
For further details see:
Clorox Non-GAAP EPS of $0.93 beats by $0.15, revenue of $1.74B beats by $40M